+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 0 - 18Years
All Genders
ID07295691

Evaluating Autologous Serum Eye Drops for Children Under 18 with Moderate to Severe Dry Eye Syndrome

Led by The General Authority for Teaching Hospitals and Institutes · Updated on 2025-12-22

70

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research aims to evaluate the clinical effectiveness and safety of autologous serum eye drops ASEDs in children under 18 years old who have moderate to severe dry eye syndrome that does not improve with conventional artificial tear treatment. Dry eye syndrome is a common eye condition that can significantly impact quality of life. ASEDs are being studied because they contain natural components that help heal the eye surface, reduce inflammation, and stabilize tears. Participants will receive eye drops made from their own blood serum. At the start of the study, 40 mL of blood will be collected from each participant and processed by centrifugation to prepare the serum eye drops. These eye drops will then be used to treat their dry eye condition. The study does not include a comparison group or placebo. During the 12-week study, participants will have their visual acuity assessed and their eye symptoms evaluated using the Ocular Surface Disease Index OSDI. Researchers will also monitor for any side effects or adverse events. The study is designed to observe how well the eye drops work and how safe they are for children with this condition.

CONDITIONS

Brief Title

Autologous Serum Eye Drops in Dry Eye Syndrome

Research Team

H

Hossam A Hassan, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here